Antibody-Mediated Rejection
Preformed antibodies
Donor-specific antibodies (DSA) developed after transplantation
Microscopic
•
Hyperacute antibody-mediated rejection (AMR)
Fibrin thrombi in portal and central veins and sinusoids
Neutrophilic &/or fibrinoid arteritis
Patchy or massive hemorrhagic hepatocyte necrosis
•
Acute AMR (Banff criteria 2016)
Definite (all following 4 criteria required)
–
Histologic pattern of injury
–
Diffuse (> 50%) C4d deposition
–
Reasonable exclusion of other insults that might cause similar injury
Suspicious (both following criteria required)
–
C4d core + H-score = 3 or 4
Indeterminate (requires following first 2 + 3 or 4)
–
C4d-score + H-score ≥ 2
–
DSA is not available, equivocal, or negative
–
C4d is not available, equivocal, negative
–
Coexisting insult might be contributing to similar injury
•
Chronic AMR (Banff criteria 2016)
Probable (all following 4 criteria required)
–
Histologic pattern of injury
–
Recent (< 3 months) positive serum DSA
–
At least focal (> 10%) C4d deposition in portal microvasculature
–
Reasonable exclusion of other insults that might cause similar injury
Possible
–
As above, but C4d is minimal (< 10%) or absent
TERMINOLOGY
Abbreviations
•
Antibody-mediated rejection (AMR)
•
Donor-specific antibodies (DSA)
Definitions
•
Graft dysfunction mediated by antibodies directed against donor antigens
ETIOLOGY/PATHOGENESIS
Preformed Antibodies